VisageX Medical
Adjustable Facial Implants for Aesthetics and Reconstructive Surgery
StartupVisageX Medical is a startup in the Health Tech & Life Sciences sector, established in 2022. Adjustable Facial Implants for Aesthetics and Reconstructive Surgery. The company has raised a total of $880K across 2 funding rounds, currently at the Pre-Seed stage. VisageX Medical was founded by Gideon Meyer Brodnitz. Key investors include The Trendlines Group. The company has 1-10 employees. Core technologies: Materials & Substances, Implants.
With $880K in total funding, VisageX Medical is a Pre-Seed-stage company operating in Health Tech & Life Sciences. The company follows a B2B/B2C business model. Product stage: R&D. The company holds 1 patent.
- StagePre-Seed
- ProductR&D
- ModelB2B, B2C
- Employees1-10
- HQMisgav Regional Council, Israel
- Last Round$130K
- The Trendlines GroupLead
Gideon Meyer BrodnitzCo-founder & CEO
What does VisageX Medical do?
VisageX Medical is developing adjustable facial implants for the aesthetics and reconstructive surgery market. The technology represents a game-changing platform in the field of plastic and reconstructive surgery, offering unparalleled flexibility and personalized aesthetic outcomes. Our mission: To become the recognized leader for Adjustable Implants tailored to each patient’s individual needs and expectations.
How much funding has VisageX Medical raised?
VisageX Medical has raised $880K in total funding across 2 rounds. The company is currently at the Pre-Seed stage. Key investors include The Trendlines Group.
Who founded VisageX Medical?
VisageX Medical was founded in 2022 by Gideon Meyer Brodnitz (Co-founder & CEO).
What sector is VisageX Medical in?
VisageX Medical operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Biomaterials & Tissue Engineering, with core technologies in Materials & Substances, Implants. Target customers: Healthcare & Life Sciences, Healthcare, Providers.
Where is VisageX Medical located?
VisageX Medical is based in Misgav Regional Council, Israel.